EL
EL.En. S.p.A.
ELEAF · OTC
$17.50 +0.00% (+$0.00)
Market Cap 1.21B €
P/E Ratio 17.89x
Div. Yield 1.66%
ROE 16.31%
Bulios Fair Price
$12.6
28.0% downside
Current Price
$17.5
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ELEAF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
69 /100
Cheap P/E 17.89x
EV/EBITDA 11.26x
P/S 1.65x
Growth
10 /100
Declining EPS growth 7.85%
Rev. growth 4.29%
Book val. growth 9.53%
Profitability
57 /100
Moderate Gross margin 34.74%
Net margin 9.23%
Op. margin 12.30%
Quality
90 /100
Excellent ROIC 387.98%
ROE 16.31%
ROA N/A
Debt
100 /100
Low Debt/Equity 0.05x
Int. coverage 28.34x
Net debt/EBITDA 0.18x
Stability
89 /100
Stable Beta 1.07x
Rev. volatility 12.64%
EPS volatility 12.22%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ELEAF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Gabriele Clementi
Employees
1,412
Headquarters
Calenzano
Upcoming events
14 SEP
Earnings
Upcoming earnings report
13 NOV
Earnings
Upcoming earnings report